Showing posts with label abstract. Show all posts
Showing posts with label abstract. Show all posts

Thursday, November 19, 2026

Autochthonous #dengue #outbreak spreading from a holiday site to #visitors’ places of residence, #Tuscany, #Italy, August to October 2026

 


Abstract

Between August and October 2026, 49 autochthonous dengue cases were notified in Italy. Of these, 42 were exposed at a Tuscan coastal holiday site, and diagnosed after returning home, in 14 municipalities across seven provinces. Seven additional cases were identified, six in two areas where viraemic cases returned home and one near the holiday site. Dengue virus serotype 2, lineage 2II_F.1.1.5, was identified. When exposure occurs at holiday destinations, investigation and vector control should extend to places where cases reside.


© Creative Commons License. This work is licensed under a Creative Commons Attribution 4.0 International License.


Source: Eurosurveillance Journal, https://doi.org/10.2807/1560-7917.ES.2026.31.46.2600909

____

Structure-guided #design of a dual-antigen #mRNA #vaccine conferring broad protection against #Henipaviruses

 


Abstract

Henipaviruses (HNVs), including Nipah virus (NiV) and Hendra virus (HeV), are zoonotic paramyxoviruses with high case fatality rates and pandemic potential. Despite their threat, no licensed vaccines are currently available for human use. Here, we present a structure-guided mRNA vaccine strategy that overcomes key challenges in antigen stability, fusogenicity, and cross-protective efficacy. Using rationally engineered NiV F glycoproteins stabilized in the prefusion conformation, we identify a lead candidate (F-205) that abolishes syncytium formation and elicits high prefusion-specific antibody titers. Through systematic combinatorial screening, we determine that co-delivery of F-205 (NiV-M) and G (NiV-B) antigens via mRNA–lipid nanoparticles induces potent neutralizing and cellular immune responses. In stringent golden hamster challenge models, this vaccine confers complete survival against lethal NiV-M, NiV-B and HeV challenge, with viral RNA undetectable in lung, spleen and brain after NiV challenge and significantly reduced viral burden after HeV challenge. We also introduce surrogate assays to assess F conformation and fusion activity under standard biosafety conditions, enabling iterative antigen optimization without live-virus handling. This study defines a broadly protective, mechanistically informed vaccine platform for HNVs and provides a generalizable framework for rational design of mRNA vaccines targeting class I fusion viruses.


Source: Nature Communications, https://doi.org/10.1038/s41467-026-79459-9

____

Assessment of #Ebola virus #persistence in vitreous fluid of Ebola virus disease #survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study

 




Summary

Background

Uveitis is a known ocular manifestation in individuals who have survived Ebola virus disease (EVD). However, whether Ebola virus (EBOV; Orthoebolavirus zairense) persistence in vitreous fluid contributes to long-term sequelae of uveitis in EVD survivors remains unclear. We aimed to characterise the clinical findings and molecular and immunological findings in vitreous fluid from EVD survivors undergoing vitreoretinal surgery.

Methods

This cross-sectional study recruited EVD survivors (cohort 1), household close contacts of EVD survivors (cohort 2), and non-EVD patients with uveitis (cohort 3) from the Sierra Leone Ministry of Health’s Department of Ophthalmology or from the ongoing Sierra Leone Ministry of Health and the Lowell and Ruth Gess Eye Hospital Ebola Survivor Study (SMILE Study). EVD survivor status was based on an Ebola treatment unit certificate and confirmation in the Sierra Leone Association of Ebola Survivors registry, as well as an anti-EBOV assay. Close contacts of EVD survivors were individuals who lived in the same household as patients with EVD during the acute stage of the disease. Non-EVD patients with uveitis were individuals with vitreoretinal disease indications who were anticipated to benefit from surgical intervention. All patients had a comprehensive ophthalmic examination and pars plana vitrectomy with collection of vitreous fluid. These samples were investigated for molecular detection of EBOV RNA via quantitative RT-PCR (qRT-PCR) and evaluation of Goldmann–Witmer coefficients (GWCs) to identify intraocular production of EBOV-binding antibodies. Statistical analyses were performed to compare basic ophthalmic variables, demographic data, and GWC between the three groups.

Findings

From Jan 1, 2023, to Jan 1, 2024, a total of 25 patients (cohort 1 n=10, cohort 2 n=5, cohort 3 n=10) were enrolled. 13 (52%) patients were female, and median age was 39 years (IQR 34·0–53·5). The median time from EVD symptom onset to surgery was 108·5 months (IQR 103·8–110·8) in cohort 1, and the median time from close contact with a patient with EVD to surgery was 106·0 months (IQR 103·0–106·0) in cohort 2. EBOV RNA was detected by qRT-PCR in the vitreous fluid of two (20%) of ten EVD survivors. GWCs for EBOV glycoprotein IgG were significantly elevated (median 3·59, IQR 0·93–12·53, p<0·005 for between-group comparisons) in EVD survivors compared with those in close contacts (median 0, IQR 0–2·2) and patients with uveitis (median 0, IQR 0–0·62).

Interpretation

The detection of virus-specific immune responses and viral RNA at a median of 9 years after EVD diagnosis suggests long-term EBOV RNA persistence in the vitreous fluid of EVD survivors with vitreoretinal disease.

Funding

National Eye Institute of the National Institutes of Health, National Cancer Institute, National Institutes of Health, and Australian National Health and Medical Research Council.


Source: The Lancet Microbe, https://doi.org/10.1016/j.lanmic.2026.101547

____

Wednesday, November 18, 2026

Physical #distancing to prevent #ILI on a #college #campus: The eX-FLU trial

 


Abstract

Public health recommendations often advise people to isolate when infected with influenza-like illness (ILI) with the goal of promoting physical distancing and limiting face-to-face interactions when risk of transmission is highest. Because isolation may have negative consequences, it is important to carefully assess whether encouragement to physically distance actually prevents cases of ILI. College campuses can be especially vulnerable to outbreaks of ILI and are ideal environments for assessing the impact of encouragement-to-physically-distance interventions. The eX-FLU cluster-randomized trial followed 579 students on a college campus over a ten-week period during flu season to evaluate such an intervention. Students in the trial were randomized to receive the intervention—encouragement to isolate in their dorm room when symptomatic for ILI—or control. Evaluating the effect of this intervention is challenging because of dependence between students in the trial and an anticipated spillover effect of the intervention. Moreover, while the intervention was designed to affect both face-to-face interactions and ILI infections, the effect on ILI infections is of primary public health interest. In this paper, a randomization-based testing procedure is proposed to assess the intervention effect specifically on ILI infections in the presence of dependent data and spillover effects. The testing procedure is shown theoretically and empirically to control the type I error rate and have good statistical power to detect an intervention effect in trials similar to eX-FLU. When applied to the eX-FLU data, this testing procedure gives moderate evidence that the intervention reduced ILI infections.


Source: Proceedings of the National Academy of Sciences of the United States of America, https://doi.org/10.1073/pnas.2626810123

____

#Air and environmental #sampling expand metagenomic viral #surveillance in Cambodian #pig #slaughterhouses

 


Abstract

Surveillance of viruses in swine depends largely on the sampling of individual animals chosen at random, often limiting detection breadth. Environmental sampling has emerged as an alternative strategy, enabling faster, safer and more cost-effective pathogen monitoring at the human-animal interfaces. Across nine visits to two Cambodian slaughterhouses, we applied metagenomic sequencing to air samples (n = 25), faeces (n = 156), wastewater (n = 15), carcass wash water (n = 18), holding-pen swabs (n = 124), slaughter-box swabs (n = 73) and ropes (n = 16), comparing virus composition to pig snout swabs (n = 193). Combined environmental sampling recovered 96.6% of the viral taxa detected in snout swabs, exceeding 90.9% at every visit. Greater viral diversity was consistently captured in the environment, including swine-associated taxa absent from snout swabs and viral RNA associated with avian and human hosts. Air provided the widest coverage of any single environmental sample type and contributed the largest number of independent virus detections that were not recovered from any other environmental sample. Slaughter-box swabs recovered the fewest taxa, showing that visible contamination with swine material did not correlate with greater viral recovery. Overall, this study identifies air as a pivotal core component of any surveillance program. However, pairing air with additional environmental sample types provides the broadest virus coverage and represents the optimal surveillance strategy in swine slaughterhouses.


Competing Interest Statement

The authors have declared no competing interest.


Funder Information Declared

Gates Foundation, INV-049293

National Institute of Allergy and Infectious Diseases, 12-312-0217530, 1U01AI151378-01, 75N93021C00016

Food and Agriculture Organization of the United Nations

Duke-NUS Signature Research Programme

National Research Foundation, Singapore, FY2025-NRF-PA-0002


Source: BioRxIV, https://doi.org/10.64898/2026.11.16.765117

____

Sunday, November 15, 2026

#Zoonotic #infections and genomic #evolution of novel #reassortant swine #influenza A viruses in #Spain

 


Abstract

Influenza A virus (IAV) circulates widely in European pig populations and continues to diversify through frequent introductions from humans, followed by reassortment within swine. Spain represents a particularly dynamic ecological setting due to the coexistence of intensive white-pig production, extensive Iberian-pig systems, and abundant wild boar populations. This study provides an integrated analysis of IAV evolution and genomic diversity in swine in Spain between 2019 and 2022, expanding on previous surveillance from 2016 to 2019. Sampling across 24 provinces yielded 66 new whole-genome sequences from Iberian and white pigs. We identified 18 genotypes, including 11 novel reassortants not detected in our previous survey. Several genotypes, such as H1N2 G21 and G22, H3N2 G23, and the unusual H3N1 G12, were exclusive to the country. Some genotypes were detected across white pigs, Iberian pigs, and wild boar in Toledo and Badajoz, suggesting viral flow among swine populations. Phylogenetic analyses revealed ongoing introductions of H1N1pdm09 from humans into pigs, generating at least five reassortant genotypes (G10, G16–G19). These lineages incorporated pandemic internal cassettes and, in some cases, human-seasonal N2 segments, highlighting the continued role of humans as a source of viral incursions. Conversely, four zoonotic infections (H1N1v) detected in Spain between 2022 and 2026 were linked to genotypes circulating in white pigs, underscoring the bidirectional nature of IAV transmission at the human swine interface. Overall, this study demonstrates that Spain provides ecological conditions conducive to IAV diversification, reassortment, and zoonotic risk. The findings reinforce the need for sustained One Health surveillance.


Source: Virus Evolution Journal, https://doi.org/10.1093/ve/veag067

____

#H9N2 avian #influenza virus in #Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved #antigenic phenotype

 


Abstract

Low pathogenic avian influenza (LPAI) H9N2 viruses are endemic in poultry across Bangladesh, causing substantial economic losses and posing a persistent zoonotic risk. Although genetic surveillance has documented ongoing viral evolution, the relationship between genetic diversification and antigenic change remains poorly understood. This study investigated the genetic diversity, reassortment, and antigenic characteristics of contemporary H9N2 viruses circulating in Bangladesh. Phylogenetic analysis of 219 sampled sequences revealed three genetically distinct monophyletic haemagglutinin (HA) G-lineage sub-groups, each characterised by unique amino acid substitutions. In contrast, neuraminidase (NA) displayed similar genetic diversity without distinct phylogenetic clusters. A dual-metric analysis of paired HA and NA phylogenies identified 20 putative reassortant H9N2 viruses. Further analysis showed that genetic diversity was geographically structured; however, all three HA subgroups co-circulated across multiple regions, and some live bird markets contained representatives of all three groups simultaneously, suggesting that live bird markets may facilitate mixing between genetically distinct viruses, and create opportunities for reassortment among otherwise geographically separated strains. Despite substantial genetic diversity and reassortment, all viruses remained antigenically similar based on haemagglutination inhibition and virus neutralisation assays. However, a representative strain from one subgroup induced significantly lower homologous and heterologous antibody titres, suggesting reduced immunogenicity. Our findings demonstrate a notable disconnect between genetic evolution and antigenic change in Bangladeshi H9N2 viruses. While reassortment and genetic diversification continue to shape viral populations, antigenic properties remain largely conserved, supporting the continued relevance of current vaccine strategies while highlighting the importance of ongoing genetic and antigenic surveillance.


Source: BioRxIV, https://doi.org/10.64898/2026.11.13.766375

____

Saturday, November 14, 2026

Naturally Occurring #PB2 Paired Substitutions Confer Host-Dependent #Polymerase Phenotypes in #H7N9 Avian #Influenza Viruses with Differential ANP32 Support

 


Simple Summary

H7N9 avian influenza viruses circulate in poultry and can infect humans. Changes in the viral PB2 protein can affect how efficiently the virus copies its genetic material, but the effects of naturally occurring combinations of these changes remain unclear. We analyzed H7N9 PB2 sequences collected from birds and humans between 2013 and 2025 and identified several recurring combinations with different patterns over time. Laboratory experiments showed that four combinations reduced polymerase activity in human cells but caused no significant changes in chicken cells. Individual changes did not always produce the same effects when combined. ANP32 overexpression produced different polymerase activity responses under the tested cellular conditions. These findings show that the tested PB2 combinations can affect polymerase reporter activity differently in human 293T and chicken DF1 cells.


Abstract

H7N9 avian influenza viruses have caused repeated human infections since 2013, but the effects of naturally occurring PB2 substitution combinations on polymerase activity remain poorly understood. We analyzed 899 avian-derived and 1087 human-derived H7N9 PB2 sequences collected between 2013 and 2025. Six PB2 positions (109, 122, 191, 340, 559, and 640) showed distinct frequency changes across epidemic waves and host origins. Pairwise analysis identified five representative combinations with different temporal patterns. In minigenome assays, four paired substitutions reduced polymerase activity in human 293T cells at both 33 °C and 37 °C, whereas none of the five significantly altered activity in chicken DF1 cells at 37 °C or 41 °C. Several paired substitutions showed polymerase activity profiles different from those of the corresponding single substitutions in the tested cellular assays. ANP32 overexpression experiments showed different polymerase activity responses across the tested cellular conditions. Under chicken ANP32A expression, none of the paired-substitution polymerases differed significantly from the wild type, whereas human ANP32A and ANP32B overexpression did not enhance their activity in DF1 cells. Co-immunoprecipitation confirmed detectable interactions between PB2 variants and human or chicken ANP32 proteins. Structural modeling further revealed differences in predicted PB2–ANP32A interfaces among the tested variants. Together, these results show that the tested PB2 substitution combinations produced different polymerase activity profiles in human 293T and chicken DF1 cells and exhibited different responses to ANP32 overexpression under the examined conditions. The findings provide insight into the functional consequences of PB2 evolution during H7N9 circulation.


Source: Animals Journal, https://doi.org/10.3390/ani16213535

____

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Nov. 14 '26)

 


    Arch Virol

  1. ASHRAF MA, Yue L, Raza MA, Shen B, et al
    Isolation, identification and whole genome sequence analysis of influenza B virus from Shanghai during 2023-2024.
    Arch Virol. 2026;171:317.
    PubMed         Abstract available


    Drug Saf

  2. ROMANSON B, Moro PL, Strid P, Hause A, et al
    Safety Monitoring of COVID-19 Vaccines in the Vaccine Adverse Event Reporting System (VAERS): United States, August 22, 2024-July 4, 2025.
    Drug Saf. 2026;49:1639-1648.
    PubMed         Abstract available

  3. TREGUNNO C, Deraedt Q, Cuadripani S, Verheust C, et al
    AS01(E)-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance.
    Drug Saf. 2026;49:1579-1594.
    PubMed         Abstract available


    J Gen Virol

  4. NAIR PM, Zhang Y, Starkey MR, Jhong HT, et al
    Mitogen-activated protein kinase p38-dependent phosphorylation of tristetraprolin enhances inflammatory and impairs antiviral responses to influenza virus.
    J Gen Virol. 2026;107.
    PubMed         Abstract available

  5. SOULTSIOTI M, Barcena M, Giera M, Snijder EJ, et al
    Pharmacological inhibition of coronavirus replication via modulation of host lipid metabolism.
    J Gen Virol. 2026;107:002362.
    PubMed         Abstract available

  6. BLOUQUIT-LAYE S, Cosentino G, Sitterlin D, Rameix-Welti MA, et al
    A ciliated epithelial cell line as a model for respiratory syncytial virus research.
    J Gen Virol. 2026;107.
    PubMed         Abstract available


    N Engl J Med

  7. ZHANG Q, Fouchier RAM, Moncada-Velez M, Meijer A, et al
    Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza.
    N Engl J Med. 2026;395:1963-1965.
    PubMed        


    Pediatrics

  8. JARAMILLO-CEREZO A, Parra-Buitrago A, Ulloa-Gutierrez R, Gutierrez-Tobar IF, et al
    Beyond Croup: A Phenotype-Based Perspective on Parainfluenza Virus Types in Children.
    Pediatrics. 2026 Nov 13:e2026078012. doi: 10.1542/peds.2026-078012.
    PubMed         Abstract available


    PLoS Comput Biol

  9. BECKER F, Sherratt K, Bosse NI, Funk S, et al
    The influence of ensemble size and composition on the performance of combined real-time COVID-19 forecasts.
    PLoS Comput Biol. 2026;22:e1014908.
    PubMed         Abstract available


    PLoS Med

  10. TALL S, Turtinen M, Parviainen A, Pettersson J, et al
    Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study.
    PLoS Med. 2026;23:e1005288.
    PubMed         Abstract available


    PLoS One

  11. CARMICHAEL HL, Groat D, Dinglas VD, Bose S, et al
    Association of unmet discharge needs on readmission or mortality among acute respiratory failure survivors during the COVID-19 pandemic: The Addressing Post-Intensive Care Syndrome (APICS-COVID) multicenter prospective cohort study.
    PLoS One. 2026;21:e0361770.
    PubMed         Abstract available

  12. LANG Y, Griffiths A
    Validation of chemical inactivation methods for Select Agent compliance using HPAIV and low-pathogenicity influenza A virus in tissues and cultured cells.
    PLoS One. 2026;21:e0362117.
    PubMed         Abstract available

  13. VERCHER G, Pleydell DRJ, Awada L, Tizzani P, et al
    Factors influencing the timeliness of reporting highly pathogenic avian influenza outbreaks in Europe.
    PLoS One. 2026;21:e0360917.
    PubMed         Abstract available

  14. PHILLIPS R, Wood F, Torrens-Burton A, Glennan C, et al
    Evolving concerns: A longitudinal content analysis of free-text reports from the UK COVID-19 Public Experiences (COPE) study cohort.
    PLoS One. 2026;21:e0348308.
    PubMed         Abstract available

  15. CHIBA A, Haganuma K, Nakata T, Nguyen TL, et al
    COVID-19 risk perceptions after the end of the public health emergency.
    PLoS One. 2026;21:e0348400.
    PubMed         Abstract available

  16. GOLD S, Bell F, Sheard E, Ashoori A, et al
    Characterising the longer-term impacts of highly pathogenic avian influenza outbreaks prior to 2020 on wild bird populations.
    PLoS One. 2026;21:e0360235.
    PubMed         Abstract available

  17. DAY SE, Sorresso G, Fitzpatrick M, Konty K, et al
    Estimating diabetes prevalence among NYC youth: Evidence from the Automated Student Health Record.
    PLoS One. 2026;21:e0344345.
    PubMed         Abstract available

  18. BATTAGLIA S, Attanasio M, Arnone S, Geraci A, et al
    Prolonged length of stay in the Italian emergency departments: A competing risks frailty model.
    PLoS One. 2026;21:e0361888.
    PubMed         Abstract available

  19. HAILE TG, Asres N, Gebregziabher D, Fissahaye B, et al
    Intimate partner violence against women in Ethiopia: An umbrella review of systematic reviews and meta-analyses.
    PLoS One. 2026;21:e0362748.
    PubMed         Abstract available

  20. HO TL, Pham TT, Ko EJ
    Combined monophosphoryl lipid A and alpha-Galactosyl ceramide adjuvants enhance the systemic immune response to intranasal inactivated influenza vaccination in a murine homologous challenge model.
    PLoS One. 2026;21:e0362356.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. ANKERHOLD J, Kessler S, Petric PP, Jakob C, et al
    Rare recovery of reassortants between contemporary clade 2.3.4.4b H5N1 viruses and human influenza A viruses in vitro.
    Proc Natl Acad Sci U S A. 2026;123:e2631654123.
    PubMed         Abstract available

  22. SU S, Tang YS, Li Q, Cao L, et al
    Predicting key viral mutations from within-host deep sequencing data.
    Proc Natl Acad Sci U S A. 2026;123:e2536820123.
    PubMed         Abstract available


    Vaccine

  23. SUN JW, Dodge LE, Cai S, Zhou L, et al
    Monitoring of adverse events following 2024-2025 BNT162b2 KP.2 COVID-19 vaccination in the United States.
    Vaccine. 2026;95:129296.
    PubMed         Abstract available

  24. KOCHMANN J, Halwe NJ, Barut GT, Ebert N, et al
    Boosting hybrid immunity with intranasal live-attenuated or intramuscular mRNA vaccination prevents SARS-CoV-2 XBB.1.5 transmission.
    Vaccine. 2026;95:129298.
    PubMed         Abstract available

  25. BROSZ A, Oberije J, Versage E, Elfassy A, et al
    Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged >/=18?years.
    Vaccine. 2026;96:129279.
    PubMed         Abstract available

  26. NEMOTO M, Kawanishi N, Mita H, Kambayashi Y, et al
    Discrepancy between cross-neutralizing reactivity and protection in horses suggests inactivated vaccine antisera underestimate cross-protection against equine influenza.
    Vaccine. 2026;96:129339.
    PubMed         Abstract available

Friday, November 13, 2026

#Hantaviruses: Current #insights, #lessons from the MV #Hondius #outbreak, and an urgent call to action

 


Abstract

In May 2026, a cluster of laboratory-confirmed Andes virus (ANDV) infections was reported among passengers aboard the MV Hondius, a cruise ship that originated in Argentina and sailed through the South Atlantic. The exposed population included individuals from 23 countries and resulted in at least 13 cases, including three deaths, representing the first ANDV outbreak with a multi-continental range and providing further evidence consistent with human-to-human transmission of ANDV. There are currently no approved treatments or vaccines for ANDV, necessitating rapid development of drug and prophylactic pipelines. The outbreak highlighted the strengths and inherent weaknesses of our existing public health preparedness infrastructure in response to emerging infectious diseases. In this Pearl, we highlight the epidemiology, molecular virology, evolution, virus-host interactions, clinical management, therapeutic development, and public health response to ANDV. We emphasize the need to expand genomic surveillance, standardize diagnostic protocols across public health laboratories, and accelerate the clinical translation of promising antiviral candidates to strengthen pandemic preparedness infrastructure for understudied and emerging infectious diseases.


Source: Plos Pathogens, https://doi.org/10.1371/journal.ppat.1014756

____

Characterization of #Nipah Virus Strains #Malaysia and #Bangladesh in a #Hamster #Aerosol-Exposure Model

 


Abstract

Nipah virus (NiV) is an enveloped, single-stranded, negative-sense virus that causes severe respiratory distress and neurological disease in humans. While NiV disease is associated with high mortality rates (40–70%), no FDA-approved medical countermeasures (MCM) against NiV currently exist. Phylogenetic analyses have clustered isolates from Malaysia (NiV-M) and Bangladesh (NiV-B) into two distinct circulating strains associated with unique transmission routes, clinical manifestations, and lethality rates in humans. Predominantly spread by zoonotic transmission, NiV-M yields lower case-fatality rates, mild respiratory symptoms, and severe neurological manifestations. In contrast, NiV-B showcases higher case-fatality rates, marked respiratory disease, and human-to-human transmission via respiratory secretions. NiV hamster models utilizing aerosol, oronasal, intranasal, intracranial, and intraperitoneal inoculations exist. However, aerosol infection of NiV-B in hamsters remains poorly understood, while direct strain comparisons using aerosolization as an inoculation route have yet to be performed. To establish a Syrian golden hamster model comparing NiV strain-specific disease presentations and pathologies following aerosol exposure for downstream MCM characterization, we infected SGHs with a range of NiV-M and NiV-B aerosol inocula, determined the median lethal dose (LD50) and survival curves, and further elucidated both histopathological changes and viral antigen distribution within the brain and lungs. We found increased NiV-M lethality, respiratory distress, and neurological disease, in addition to more severe pathologies and viral signal within both the brain and lungs compared to NiV-B-infected animals. Our study serves as the first to compare aerosol exposure of NiV-B versus NiV-M in a hamster model, which can subsequently be used for crucial strain-specific MCM characterizations.


Source: Viruses Journal,  https://doi.org/10.3390/v18111263

____

Post-pandemic #immunity #debt and environmental decoupling reshape #urban #influenza transmission

 


Abstract

Relaxation of COVID-19 non-pharmaceutical interventions was followed by a global resurgence of respiratory infections, yet how accumulated population susceptibility interacts with environmental forcing and human mobility remains unclear. Here we analyse ~1.88 million clinical influenza tests from Macau (2010-2025) alongside meteorology, air quality, digital information-seeking, and independent surveillance and time-resolved viral genomes from Hong Kong, benchmarked against global surveillance data. Counterfactual inference indicates a post-pandemic excess in influenza activity consistent with immunity debt, mirroring global resurgence patterns, and an independently parameterised susceptible–exposed–infectious–recovered–susceptible model reproduces this excess (best-fit debt fraction 42%; approximate Bayesian computation posterior 58%, 95% uncertainty interval 32-77%). Susceptibility rises disproportionately in adults rather than children, whereas vaccination coverage in high-risk groups does not decline, arguing against reduced uptake as the driver. Time-varying models and convergent cross mapping reveal environmental decoupling, whereby high susceptibility weakens meteorological constraints and sustains influenza A transmission, and asymmetric suppression of influenza B. Spatiotemporal and phylogenetic evidence supports travel-linked reintroduction from ports of entry into dense neighbourhoods, and digital information-seeking shifts from lagging to leading clinical burden. These findings indicate a post-pandemic regime shift in influenza dynamics rather than a return to historical baselines, motivating adaptive, multi-source surveillance in high-density cities.


Source: Nature Communications,  https://doi.org/10.1038/s41467-026-79600-8

____

Long-term local #circulation of an #Andes virus lineage in northern #Patagonia is linked to the M/V #Hondius #outbreak

 


Abstract

In 2026, a hantavirus pulmonary syndrome (HPS) outbreak caused by Andes virus (ANDV) occurred on a cruise ship. Analyses revealed an unexpected relationship to an outbreak in Argentina in 2018. Retrospective investigation clarified the 2018 outbreak could involve person-to-person transmission and a common ANDV lineage spanned HPS cases from 2018 to 2025 in a geographically defined area in northern Patagonia, without widespread community transmission of ANDV. Route reconstruction for the index cases in the cruise ship outbreak identified geographically plausible exposures to viruses of this lineage in Argentina, but their timing was inconsistent with the expected ANDV incubation period. The infection source for the cruise ship outbreak cannot be resolved with current information, highlighting the need to expand viral surveillance in the ANDV endemic region.


Source: Science Journal, https://doi.org/10.1126/science.aej1679

____

#Hantavirus pulmonary syndrome #outbreak linked to cruise #ship #travel in April–May 2026

 


Abstract

In April 2026, a hantavirus pulmonary syndrome (HPS) outbreak caused by Andes virus (ANDV) occurred on a cruise ship. ANDV genome sequences were obtained for 10 of the 13 identified cases during a cross-country investigation established to share initial raw data for joint analysis with reciprocal quality control. The genomic data, symptom onsets, and plausible contact patterns strongly support a tightly linked outbreak cluster compatible with a single or very few zoonotic spillover events prior to embarkment followed by human-to-human transmission onboard. The outbreak represents the international displacement of a virus already known to be capable, under specific conditions, to transmit among humans, and does not suggest emergence of a unusual viral strain.


Source: Science Journal, https://doi.org/10.1126/science.aej1376

____

Thursday, November 12, 2026

#Measles resurgence in #Italy: analysis of temporal patterns of viral transmission, #surveillance #performance, and #vaccination coverage at national and regional levels, October 2023 to March 2025

 


Abstract

BACKGROUND

Following substantial progress towards measles elimination after the COVID-19 pandemic, Italy experienced a marked increase in measles cases in 2024.

AIM

Our aim was to describe measles epidemiology in Italy, October 2023–March 2025, and assess vaccination coverage, surveillance performance at national and regional levels, and temporal patterns of transmission.

METHODS

Numbers of measles cases and outbreaks were reviewed. Vaccination coverage and surveillance indicators were described at national and regional levels. Measles variants were classified by genotype and Distinct Sequence Identifier (DSId). Temporal transmission patterns of measles variants were assessed nationally and regionally to identify sustained transmission chains (≥ 12 consecutive months).

RESULTS

In total, 1,311 measles cases were reported, with 178 outbreaks. Cases’ median age was 30.9 years (IQR: 15.6–39.8); 601 were female (45.8%) and 710 male (54.2%). Only 3.1% (38/1,230) were fully vaccinated. In 2024, the first-dose vaccination coverage increased to 94.77% (95% CI: 94.70–94.84%) nationally, while second-dose coverage declined to 84.45% (95% CI: 84.35–84.55%). Among all cases, 12.1% (n = 158) were imported/importation-related, 64.1% (n = 841) were of unknown origin and 52.8% had DSId data available (n = 692), with high regional heterogeneity. Twenty-five measles variants were identified. One variant (D8–5963) showed sustained national transmission for over 12 months, meeting criteria for re-established endemic transmission, although no single region showed uninterrupted ≥ 12-month circulation.

CONCLUSION

Measles resurgence in Italy was marked by persistent immunity gaps, heterogeneous surveillance performance, and sustained national circulation of a D8 variant, indicating loss of near-elimination status. Strengthening vaccination strategies and enhancing molecular surveillance is urgently needed to restore progress towards measles elimination.


Source: Eurosurveillance Journal, https://doi.org/10.2807/1560-7917.ES.2026.31.45.2600090

____

Detection of #Shamonda virus in field-collected #Culicoides (Diptera: Ceratopogonidae), #Switzerland, August to September 2026

 


Abstract

In August–September 2026, we detected Shamonda virus (SHAV) (genus Orthobunyavirus) RNA in 15 of 34 pools of 610 field-collected Culicoides biting midges (Diptera: Ceratopogonidae) of C. obsoletus group, C. circumscriptus and C. festivipennis on cattle farms in Switzerland. The overall minimum infection rate was 24.59 per 1,000 females tested. Further investigations of the role of local biting midge species in virus transmission and the potential implications for animal and human health are needed, considering possible zoonotic concerns.


Source: Eurosurveillance Journal, https://doi.org/10.2807/1560-7917.ES.2026.31.45.2600927

____

Wednesday, November 11, 2026

#Baloxavir and #molnupiravir protect against severe #influenza #H5N1 #infection in immunosuppressed hamsters

 


Abstract

Highly pathogenic avian influenza A(H5N1) viruses continue to expand their geographic and host range, raising concerns about zoonotic transmission and pandemic preparedness. Immunocompromised individuals often develop severe and prolonged disease, yet evidence guiding antiviral therapy remains limited. Here, we characterized the pathogenesis and assessed direct-contact transmission of an influenza A(H5N1) clade 2.3.4.4b genotype D1.1 virus recently isolated from a human case in British Columbia, Canada, in cyclophosphamide-immunosuppressed hamsters, with normal hamsters included for comparison of infection outcomes and viral shedding kinetics. We also evaluated the antiviral efficacy of oseltamivir (20 mg/kg twice daily for 5 days), baloxavir (50 mg/kg, 2 doses), and molnupiravir (50 or 200 mg/kg twice daily) as monotherapies or in combination (oseltamivir with low-dose molnupiravir) in immunosuppressed hamsters. While normal hamsters showed no mortality and achieved viral clearance, infection in immunosuppressed hamsters caused severe disease characterized by prolonged viral replication, neuroinvasion, and 75% mortality, with no direct-contact transmission detected. In the antiviral efficacy experiment, placebo-treated hamsters exhibited 50% mortality. Baloxavir resulted in 100% survival, shortened viral shedding, reduced viral replication and pulmonary inflammatory responses, and prevented neuroinvasion. High-dose molnupiravir also prevented mortality and achieved viral clearance in lung and brain tissues. Combination therapy resulted in 75% survival and similarly achieved viral clearance in both tissues, with reduced morbidity compared with oseltamivir and low-dose molnupiravir monotherapies. Oseltamivir resulted in 75% survival but failed to prevent severe clinical signs or reduce tissue viral titers, whereas low-dose molnupiravir showed outcomes comparable to placebo. These findings demonstrate the high pathogenicity of a human A(H5N1) isolate in immunosuppressed hamsters, support baloxavir as an effective therapeutic option, and identify molnupiravir-based regimens as promising strategies for severe influenza A(H5N1) infection.


Source: PLoS Pathogens, https://doi.org/10.1371/journal.ppat.1014796

____

#Maternal and perinatal #outcomes in pregnant women with #Lassa fever: analysis from the LASCOPE prospective cohort study

 


Summary

Background

Lassa fever, a viral haemorrhagic fever endemic in west Africa, is usually described as associated with severe maternal and perinatal outcomes. Previous studies reported maternal mortality of 33% (whereas overall mortality is about 14% in Nigeria for patients admitted to hospital) and fetal mortality is up to 60%. However, most evidence derives from small case series with substantial limitations. We aimed to assess maternal death and perinatal outcomes in a prospective cohort study with standardised medical care protocols.

Methods

We analysed data from the LASCOPE cohort from the Federal Medical Centre Owo, Nigeria, which included all patients with PCR-confirmed Lassa fever. In this analysis, non-pregnant women of childbearing age (15–45 years) were compared with pregnant women, defined as having an ongoing pregnancy during Lassa fever. The primary maternal outcome was all-cause mortality 28 days after admission and the primary pregnancy outcome was fetal death. Mortality at 28 days was compared using Kaplan–Meier estimates and a Cox proportional-hazards model, the cumulative incidence of fetal death was estimated with livebirth as a competing event, and the association between gestational age at symptom onset and fetal death was assessed by logistic regression.

Findings

Between April 4, 2018, and Feb 18, 2023, of 1006 patients in the LASCOPE cohort admitted with PCR-confirmed Lassa fever, 703 were excluded for not being of childbearing age, and 303 were women of childbearing age, of whom 45 were pregnant. The median age of pregnant women was 28 years (IQR 24–32). The 28-day mortality was comparable between pregnant and non-pregnant women (four [9%; 95% CI 2–21] of 45 vs 19 [7%; 95% CI 4–11] of 258; hazard ratio 1·19 [95% CI 0·41–3·50]; log-rank p=0·75). Fetal case-fatality rate was 60% (27 of 45), with higher risk of fetal death if infection occurred early in the pregnancy (100% for the first trimester, 82% for the second trimester, and 25% for the third trimester). Each additional week of gestation at symptom onset was associated with a reduction in the odds of fetal death (odds ratio 0·77 [95% CI 0·61–0·90]). Among 15 liveborn infants, three (20%) died within 30 days.

Interpretation

Although the fetal prognosis was poor, as previously reported, maternal fatality was lower than previously indicated, potentially reflecting improved supportive care and patient monitoring. These findings suggest that maternal mortality might be lower than historically reported, while confirming the urgent need for specific therapeutic interventions to improve fetal outcomes.

Funding

INSERM/REACTing; the African Coalition for Epidemic Research, Response and Training consortium; the University of Oxford; the UK Department for International Development; the Wellcome Trust; the French Ministry of Foreign Affairs; the Agence Nationale de Recherches sur le SIDA et les hépatites virales; and the French National Research Institute for Sustainable Development.


Source: The Lancet Infectious Diseases, https://doi.org/10.1016/S1473-3099(26)00524-4

____

Tuesday, November 10, 2026

#Transmission #dynamics of #Nipah virus in #Bangladesh and India, 2001–2026: Systematic review and inference on reproduction number, offspring dispersion, and serial interval

 


Abstract

Background

Nipah virus (NiV) is a priority zoonotic pathogen causing high-fatality outbreaks. Early NiV outbreaks in Malaysia and Singapore had limited transmission beyond spillover events. However, since 2001, NiV outbreaks with person-to-person transmission have occurred in Bangladesh and India, driven by the NiV-Bangladesh genotype and NiV-India genotype. Our study aims to estimate the reproduction number, offspring dispersion, and serial interval governing NiV transmission in Bangladesh and India during 2001–2026.

Methods

We conducted a systematic review of NiV outbreak investigations in Bangladesh and India, searching PubMed, Embase, Web of Science, and grey literature through 28 February 2026. Case-level offspring counts from 27 sources (323 cases across 67 outbreaks) were used as input to a hierarchical Bayesian negative binomial offspring distribution model. The serial interval was estimated by parametric distribution fitting to 137 transmission pairs. We conducted country-specific analysis and performed sensitivity analyses to evaluate the robustness of estimates.

Results

Pooling across 67 outbreaks, we estimated a median reproduction number of 0.43 (95% CrI: 0.26–0.75), an offspring dispersion parameter of 0.04 (0.03–0.06), and a serial interval of 13.3 days (95% CI: 12.8–13.8). Country-specific median reproduction numbers were 0.47 (0.22–0.98) for India and 0.35 (0.19–0.63) for Bangladesh, and dispersion parameters were 0.03 (0.02–0.06) and 0.05 (0.03–0.09), respectively, indicating marked overdispersion in both settings.

Conclusion

NiV transmission is self-limiting on average and highly overdispersed, suggesting that a disproportionate share of onward transmission arises from a small number of cases. This epidemiological profile supports targeted containment measures, including contact tracing and quarantine, for effective NiV outbreak control.


Source: Plos Neglected Tropical Diseases, https://doi.org/10.1371/journal.pntd.0014876

____

Cross #Protection against #Influenza #H5 Clade 2.3.4.4b Viruses after #H1N1pdm09 Infection

 


Abstract

We challenged ferrets previously infected with influenza A(H1N1)pdm09 virus with H5N1 or H5N5 clade 2.3.4.4b viruses to assess cross-protection. Results show that previous A(H1N1)pdm09 virus immunity conferred partial protection against both viruses, with slightly reduced protection against H5N5 compared with H5N1, potentially reflecting the absence of cross-reactive N5 neuraminidase antibodies.


Source: Emerging Infectious Diseases Journal, https://doi.org/10.3201/eid3212.261032

____

My New Space

Most Popular Posts